Lattulosio Aurobindo (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged, where intestinal bacteria break it down into short‑chain fatty acids. These acids raise the osmotic pressure, drawing water into the bowel to soften stool, and they acidify the colonic contents, converting ammonia to non‑absorbable ammonium, thereby decreasing systemic ammonia.

The dose of lactulose is individualized by the prescribing clinician based on the patient’s condition, age, and response. Typical regimens differ for constipation versus hepatic encephalopathy, and adjustments are made according to therapeutic effect and tolerability.

Safety data for lactulose in pregnancy and lactation are limited. It is classified as a category where benefits must be weighed against potential risks. Healthcare providers should evaluate each case and consider alternative treatments if appropriate.

To request Lattulosio Aurobindo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lactulose differs from agents such as polyethylene glycol in that it is metabolized by colonic bacteria to produce acids, providing both laxative and ammonia‑lowering effects. Polyethylene glycol acts solely as an osmotic agent without influencing colonic pH, making lactulose the preferred choice when hepatic encephalopathy is also a concern.

Lattulosio Aurobindo should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Lattulosio Aurobindo is taken orally, usually as a liquid solution. The dose is measured with a calibrated device or spoon as directed by the prescriber, and it can be taken with or without food. Adequate fluid intake is recommended to support its laxative effect.

Serious risks include severe electrolyte disturbances such as hypokalemia, dehydration from excessive diarrhea, and rare allergic reactions presenting as rash, itching or swelling. Patients should seek medical attention if they experience persistent watery stools, muscle weakness, or signs of an allergic response.

Lactulose is contraindicated in individuals with a known hypersensitivity to the drug, in patients with complete mechanical bowel obstruction, and in those with severe renal impairment unless closely monitored. It should also be used with caution in patients prone to electrolyte imbalances.